All data are based on the daily closing price as of January 14, 2025
g

Grape King Bio

1707.TW
4.44 USD
-0.03
-0.67%

Overview

Last close
4.44 usd
Market cap
657.52M usd
52 week high
5.08 usd
52 week low
4.08 usd
Target price
5.32 usd

Valuation

P/E
14.858
Forward P/E
17.3611
Price/Sales
1.9989
Price/Book Value
2.1879
Enterprise Value
566.94M usd
EV/Revenue
1.6702
EV/EBITDA
5.8224

Key financials

Revenue TTM
328.90M usd
Gross Profit TTM
257.06M usd
EBITDA TTM
86.25M usd
Earnings per Share
0.3 usd
Dividend
N/A usd
Total assets
462.77M usd
Net debt
N/A usd

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distribution; and Original Design Manufacturer/Original Equipment Manufacturer segments. The company offers Chinese herbal, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, weight control, liver care, brain health, eye care, feminine health, and sensual health care. It also provides functional ingredients, microbial fermentation, and food inspection services. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
  • Symbol
    1707.TW
  • Exchange
    TW
  • Isin
    TW0001707008
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Bing-Jyun Cuei
  • Headquarter
    Taoyuan City
  • Web site
    https://www.grapeking.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top